• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Takayasu 动脉炎伴血脂异常增加动脉瘤风险。

Takayasu Arteritis with Dyslipidemia Increases Risk of Aneurysm.

机构信息

Department of Rheumatology and Immunology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Department of Pathology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

出版信息

Sci Rep. 2019 Oct 1;9(1):14083. doi: 10.1038/s41598-019-50527-z.

DOI:10.1038/s41598-019-50527-z
PMID:31575993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6773689/
Abstract

Low-density lipoprotein cholesterol (LDL-C) has been associated with the occurrence of abdominal aortic aneurysm. However, whether LDL-C elevation associated with aneurysms in large vessel vasculitis is unknown. The aim of this study is to investigate the clinical and laboratory features of Takayasu arteritis (TAK) and explore the risk factors that associated with aneurysm in these patients. This retrospective study compared the clinical manifestations, laboratory parameters, and imaging results of 103 TAK patients with or without aneurysms and analyzed the risk factors of aneurysm formation. 20.4% of TAK patients were found to have aneurysms. The LDL-C levels was higher in the aneurysm group than in the non-aneurysm group (2.9 ± 0.9 mmol/l vs. 2.4 ± 0.9 mmol/l, p = 0.032). Elevated serum LDL-C levels increased the risk of aneurysm by 5.8-fold (p = 0.021, odds ratio [OR] = 5.767, 95% confidence interval [CI]: 1.302-25.543), and the cutoff value of level of serum LDL-C was 3.08 mmol/l. The risk of aneurysm was 4.2-fold higher in patients with disease duration >5 years (p = 0.042, OR = 4.237, 95% CI: 1.055-17.023), and 2.9-fold higher when an elevated erythrocyte sedimentation rate was present (p = 0.077, OR = 2.851, 95% CI: 0.891-9.115). In this study, elevated LDL-C levels increased the risk of developing aneurysms in patients with TAK.

摘要

低密度脂蛋白胆固醇(LDL-C)与腹主动脉瘤的发生有关。然而,尚不清楚大血管血管炎中 LDL-C 升高是否与动脉瘤有关。本研究旨在探讨大动脉炎(TAK)的临床和实验室特征,并探讨与这些患者动脉瘤相关的危险因素。本回顾性研究比较了 103 例 TAK 患者伴或不伴动脉瘤的临床表现、实验室参数和影像学结果,并分析了动脉瘤形成的危险因素。20.4%的 TAK 患者发现有动脉瘤。与无动脉瘤组相比,动脉瘤组的 LDL-C 水平更高(2.9±0.9mmol/L 比 2.4±0.9mmol/L,p=0.032)。血清 LDL-C 水平升高使动脉瘤的风险增加 5.8 倍(p=0.021,优势比[OR]=5.767,95%置信区间[CI]:1.302-25.543),血清 LDL-C 水平的临界值为 3.08mmol/L。病程>5 年的患者发生动脉瘤的风险增加 4.2 倍(p=0.042,OR=4.237,95%CI:1.055-17.023),红细胞沉降率升高的患者发生动脉瘤的风险增加 2.9 倍(p=0.077,OR=2.851,95%CI:0.891-9.115)。在本研究中,升高的 LDL-C 水平增加了 TAK 患者发生动脉瘤的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df4/6773689/ad7ec8ec1d68/41598_2019_50527_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df4/6773689/a3dffd12b930/41598_2019_50527_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df4/6773689/a6587e202a71/41598_2019_50527_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df4/6773689/ad7ec8ec1d68/41598_2019_50527_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df4/6773689/a3dffd12b930/41598_2019_50527_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df4/6773689/a6587e202a71/41598_2019_50527_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4df4/6773689/ad7ec8ec1d68/41598_2019_50527_Fig3_HTML.jpg

相似文献

1
Takayasu Arteritis with Dyslipidemia Increases Risk of Aneurysm.Takayasu 动脉炎伴血脂异常增加动脉瘤风险。
Sci Rep. 2019 Oct 1;9(1):14083. doi: 10.1038/s41598-019-50527-z.
2
Serum concentrations of small dense low-density lipoprotein cholesterol and lipoprotein(a) are related to coronary arteriostenosis in Takayasu arteritis.血清中小而密的低密度脂蛋白胆固醇和脂蛋白(a)浓度与大动脉炎的冠状动脉狭窄有关。
J Clin Lab Anal. 2021 Dec;35(12):e23966. doi: 10.1002/jcla.23966. Epub 2021 Oct 28.
3
The relationships of serum homocysteine levels and traditional lipid indicators with disease activity and coronary artery involvement in Takayasu arteritis.血清同型半胱氨酸水平与传统血脂指标与大动脉炎疾病活动度及冠状动脉受累的关系。
Immunol Res. 2020 Dec;68(6):405-413. doi: 10.1007/s12026-020-09157-1. Epub 2020 Oct 16.
4
Intravenous tocilizumab for Takayasu arteritis with aortic aneurysms, bilateral renal artery stenosis, and atypical aortic coarctation in a 2-year-old girl.静脉注射托珠单抗治疗一名2岁女童的高安动脉炎,该女童伴有主动脉瘤、双侧肾动脉狭窄和非典型主动脉缩窄。
Mod Rheumatol Case Rep. 2023 Jan 3;7(1):160-165. doi: 10.1093/mrcr/rxac068.
5
Gut dysbiosis is associated with aortic aneurysm formation and progression in Takayasu arteritis.肠道菌群失调与 Takayasu 动脉炎主动脉瘤的形成和进展有关。
Arthritis Res Ther. 2023 Mar 24;25(1):46. doi: 10.1186/s13075-023-03031-9.
6
Aneurysms in Takayasu's arteritis: a retrospective study of Chinese patients.Takayasu 动脉炎中的动脉瘤:中国患者的回顾性研究。
Clin Exp Rheumatol. 2020 Mar-Apr;38 Suppl 124(2):42-47. Epub 2019 Dec 6.
7
Assessment of disease activity in Takayasu arteritis: A quantitative study with computed tomography angiography.Takayasu 动脉炎疾病活动度评估:一项基于 CT 血管造影的定量研究。
Int J Cardiol. 2019 Aug 15;289:144-149. doi: 10.1016/j.ijcard.2019.04.086. Epub 2019 May 2.
8
Development of a score for assessment of radiologic damage in large-vessel vasculitis (Combined Arteritis Damage Score, CARDS).大血管血管炎放射学损伤评估评分系统的开发(联合动脉炎损伤评分,CARDS)。
Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):139-145. Epub 2017 Mar 13.
9
Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity?大血管血管炎的临床特征和影像学表现:高安动脉炎和巨细胞动脉炎是两种不同的疾病还是同一实体?
J Rheumatol. 2015 Feb;42(2):300-8. doi: 10.3899/jrheum.140562. Epub 2014 Nov 15.
10
Current Clinical Features of New Patients With Takayasu Arteritis Observed From Cross-Country Research in Japan: Age and Sex Specificity.日本跨国研究观察到的新 Takayasu 动脉炎患者的当前临床特征:年龄和性别特异性。
Circulation. 2015 Nov 3;132(18):1701-9. doi: 10.1161/CIRCULATIONAHA.114.012547. Epub 2015 Sep 9.

引用本文的文献

1
Targeting cholesterol-driven pyroptosis: a promising strategy for the prevention and treatment of atherosclerosis.靶向胆固醇驱动的细胞焦亡:一种防治动脉粥样硬化的有前景策略。
Mol Biol Rep. 2025 May 15;52(1):459. doi: 10.1007/s11033-025-10554-8.
2
Exceptional multisite aneurysms in Takayasu arteritis: A unique and challenging case.大动脉炎中的罕见多部位动脉瘤:一个独特且具有挑战性的病例。
Radiol Case Rep. 2024 May 22;19(8):3345-3348. doi: 10.1016/j.radcr.2024.04.056. eCollection 2024 Aug.
3
Age, sex and angiographic type-related phenotypic differences in inpatients with Takayasu arteritis: A 13-year retrospective study at a national referral center in China.

本文引用的文献

1
Assessing the Risk of Aortic Aneurysm in Takayasu Arteritis.
Am J Med Sci. 2017 Dec;354(6):531-532. doi: 10.1016/j.amjms.2017.09.014. Epub 2017 Oct 4.
2
Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm: A Meta-analysis.脂质和脂质药物靶点与腹主动脉瘤的遗传关联:一项荟萃分析。
JAMA Cardiol. 2018 Jan 1;3(1):26-33. doi: 10.1001/jamacardio.2017.4293.
3
The protease inhibitor E64d improves ox-LDL-induced endothelial dysfunction in human aortic endothelial cells.蛋白酶抑制剂E64d可改善人主动脉内皮细胞中氧化型低密度脂蛋白诱导的内皮功能障碍。
大动脉炎住院患者的年龄、性别及血管造影类型相关表型差异:中国一家国家级转诊中心的13年回顾性研究
Front Cardiovasc Med. 2023 Mar 16;10:1099144. doi: 10.3389/fcvm.2023.1099144. eCollection 2023.
4
Prevalence and Risk Factors for Unruptured Intracranial Aneurysms in the Population at High Risk for Aneurysm in the Rural Areas of Tianjin.天津市农村地区动脉瘤高危人群中未破裂颅内动脉瘤的患病率及危险因素
Front Neurol. 2022 Mar 23;13:853054. doi: 10.3389/fneur.2022.853054. eCollection 2022.
5
Vertebral and carotid artery aneurysms and polyarthritis in a patient with Takayasu arteritis: A case report.一名大动脉炎患者并发椎动脉和颈动脉动脉瘤及多关节炎:病例报告
Radiol Case Rep. 2022 Jan 5;17(3):832-842. doi: 10.1016/j.radcr.2021.11.041. eCollection 2022 Mar.
6
Low Carotid Flow Pulsatility Index Correlates With the Presence of Unruptured Intracranial Aneurysms.低颈总动脉搏动指数与未破裂颅内动脉瘤的存在相关。
J Am Heart Assoc. 2021 Jul 6;10(13):e018626. doi: 10.1161/JAHA.120.018626. Epub 2021 Jun 22.
7
Physical Exercise in Managing Takayasu Arteritis Patients Complicated With Cardiovascular Diseases.运动锻炼在合并心血管疾病的大动脉炎患者管理中的应用
Front Cardiovasc Med. 2021 May 12;8:603354. doi: 10.3389/fcvm.2021.603354. eCollection 2021.
8
Factors associated with event-free survival in Chinese patients with Takayasu's arteritis.与中国 Takayasu 动脉炎患者无事件生存相关的因素。
Clin Rheumatol. 2021 May;40(5):1941-1948. doi: 10.1007/s10067-020-05481-x. Epub 2020 Nov 2.
Can J Physiol Pharmacol. 2018 Feb;96(2):120-127. doi: 10.1139/cjpp-2017-0016. Epub 2017 Aug 30.
4
Aortic Wall Inflammation Predicts Abdominal Aortic Aneurysm Expansion, Rupture, and Need for Surgical Repair.主动脉壁炎症可预测腹主动脉瘤的扩张、破裂及手术修复需求。
Circulation. 2017 Aug 29;136(9):787-797. doi: 10.1161/CIRCULATIONAHA.117.028433. Epub 2017 Jul 18.
5
Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis: A Multicenter Study of 318 Patients.大动脉炎并发症的长期预后和预测因素:一项 318 例患者的多中心研究。
Circulation. 2017 Sep 19;136(12):1114-1122. doi: 10.1161/CIRCULATIONAHA.116.027094. Epub 2017 Jul 12.
6
Crosstalk Between Enzyme Matrix Metalloproteinases 2 and 9 and Regulatory T Cell Immunity in the Global Burden of Atherosclerosis.酶基质金属蛋白酶2和9与动脉粥样硬化全球负担中调节性T细胞免疫之间的相互作用
Scand J Immunol. 2017 Jul;86(1):65-71. doi: 10.1111/sji.12563.
7
Lifetime Risk and Risk Factors for Abdominal Aortic Aneurysm in a 24-Year Prospective Study: The ARIC Study (Atherosclerosis Risk in Communities).一项为期24年的前瞻性研究:社区动脉粥样硬化风险研究(ARIC研究)中腹主动脉瘤的终生风险及风险因素
Arterioscler Thromb Vasc Biol. 2016 Dec;36(12):2468-2477. doi: 10.1161/ATVBAHA.116.308147. Epub 2016 Nov 10.
8
Hypercholesterolemia Induced by a PCSK9 Gain-of-Function Mutation Augments Angiotensin II-Induced Abdominal Aortic Aneurysms in C57BL/6 Mice-Brief Report.PCSK9功能获得性突变诱导的高胆固醇血症加剧C57BL/6小鼠中血管紧张素II诱导的腹主动脉瘤——简要报告
Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1753-7. doi: 10.1161/ATVBAHA.116.307613. Epub 2016 Jul 28.
9
Cause of death in Chinese Takayasu arteritis patients.中国大动脉炎患者的死因
Medicine (Baltimore). 2016 Jul;95(27):e4069. doi: 10.1097/MD.0000000000004069.
10
Aortic Aneurysm: Etiopathogenesis and Clinicopathologic Correlations.主动脉瘤:病因发病机制与临床病理相关性
Ann Vasc Dis. 2016;9(2):73-9. doi: 10.3400/avd.ra.16-00018. Epub 2016 Apr 7.